The U.S. Food and Drug Administration has gone to court to stop an Atoka company from allegedly selling products containing colloidal silver as a remedy for COVID-19.

The FDA, in a civil lawsuit filed Wednesday, claims Xephyr LLC, doing business as N-Ergetics, asserts on its company website and on product literature that colloidal silver “cures, mitigates or treats coronavirus and other diseases,” according to a complaint filed in Muskogee federal court.

The lawsuit names company owners Brad Brand, Derill J. Fussell and Linda Fussell as defendants along with the company.

The lawsuit alleges N-Ergetics offers on its website colloidal silver products for sale in the U.S. that it claims are intended to cure, mitigate, treat, or prevent coronaviruses, including COVID-19 and other diseases, including urinary tract infections, yeast infections and pink eye.

The lawsuit describes a web page with the heading “Human Coronavirus” on the N-Ergetics website as evidence of the alleged unlawful claims.

Colloidal silver, according to the U.S. Department of Health and Human Services, “consists of tiny silver particles in a liquid that is sometimes promoted on the Internet as a dietary supplement. However, evidence supporting health-related claims is lacking. In fact, colloidal silver can be dangerous to your health.”

Source:  Tulsa World